Abstract

High Incidence of Herpes Zoster in Patients Using Ruxolitinib for Myeloproliferative Neoplasms: Need for Prophylaxis.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
184-LB: Incidence of Herpes Zoster in Patients with Type 2 Diabetes and Consequences for Treatment
Jean-Etienne Poirrier ... Serge Jabbour
Diabetes | VOL. 69
Jean-Etienne Poirrier, et. al.Jean-Etienne Poirrier ... Serge Jabbour
01 Jun 2020
Incidence of Herpes Zoster in Patients With Rheumatoid Arthritis in the United States: A Retrospective Cohort Study.
David Singer ... Deepshekhar Gupta
The Journal of rheumatology | VOL. 50
David Singer, et. al.David Singer ... Deepshekhar Gupta
01 Feb 2023
Incidence and Risk Factors for Developing Herpes Zoster Among a Cohort of Patients Diagnosed with Lymphoma at a Community Cancer Center
Fernando Cabanillas ... Joel Rivera Concepcion
Blood | VOL. 132
Fernando Cabanillas, et. al.Fernando Cabanillas ... Joel Rivera Concepcion
29 Nov 2018
The Incidence and Clinical Characteristics of Herpes Zoster Among Children and Adolescents After Implementation of Varicella Vaccination
Aisha Jumaan ... Han Wu
Pediatric Infectious Disease Journal | VOL. 28
Aisha Jumaan, et. al.Aisha Jumaan ... Han Wu
01 Nov 2009
View more papers

More From: HemaSphere

Paper Title
Journal
Date
Author
An integrated classification of tumor suppressor IKZF1 inactivation and oncogenic activation in Philadelphia chromosome-like acute lymphoblastic leukemia.
Zicong Huang ... Hongsheng Zhou
HemaSphere | VOL. 8
Zicong Huang, et. al.Zicong Huang ... Hongsheng Zhou
01 May 2024
Interplay between α-thalassemia and β-hemoglobinopathies: Translating genotype-phenotype relationships into therapies.
Jim Vadolas ... George Grigoriadis
HemaSphere | VOL. 8
Jim Vadolas, et. al.Jim Vadolas ... George Grigoriadis
01 May 2024
Towarda more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS).
Fabio Efficace ... Amer M Zeidan
HemaSphere | VOL. 8
Fabio Efficace, et. al.Fabio Efficace ... Amer M Zeidan
01 May 2024
-
-
HemaSphere | VOL. 8
--
01 May 2024
View more papers